<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02917707</url>
  </required_header>
  <id_info>
    <org_study_id>Y219J11311</org_study_id>
    <nct_id>NCT02917707</nct_id>
  </id_info>
  <brief_title>Integrative Analysis of CRC Liver Metastasis</brief_title>
  <acronym>CRC-LM</acronym>
  <official_title>Integrative Analysis of CRC Liver Metastasis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Da Fu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ganzhou City People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shanghai 10th People's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will perform integrative analysis of CRC liver metastasis
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will analyzed proteomes of paired normal colorectal tissues and colorectal
      cancer (CRC) with or without liver metastasis, sequenced transcriptomes, performed whole
      exome sequencing, and single nucleotide polymorphism (SNP) array profiling for triplets, each
      comprising normal colorectal tissue, primary colorectal carcinoma, and its synchronous
      matched liver metastasis, as well as analyzed genomics of CRC characterized previously by The
      Cancer Genome Atlas (TCGA) to conduct integrated proteogenomic analyses.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">December 2026</completion_date>
  <primary_completion_date type="Anticipated">December 2026</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>5 years overall survival</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>5 years disease-free survival</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Metastasis</condition>
  <arm_group>
    <arm_group_label>normal colorectal tissues (PN)</arm_group_label>
    <description>normal colorectal tissues</description>
  </arm_group>
  <arm_group>
    <arm_group_label>primary colorectal carcinoma tissues</arm_group_label>
    <description>primary colorectal carcinoma tissues</description>
  </arm_group>
  <arm_group>
    <arm_group_label>liver metastasis tissues</arm_group_label>
    <description>liver metastasis tissues</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>normal colorectal tissues</intervention_name>
    <description>The investigators will extract total protein, DNA and RNA from these groups.</description>
    <arm_group_label>normal colorectal tissues (PN)</arm_group_label>
    <arm_group_label>primary colorectal carcinoma tissues</arm_group_label>
    <arm_group_label>liver metastasis tissues</arm_group_label>
    <other_name>primary colorectal carcinoma tissues</other_name>
    <other_name>liver metastasis tissues</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with CRC
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≤ 75 years with histologically proven CRC

          -  No severe major organ dysfunction

          -  WHO performance status of 0 or 1

          -  No prior cancer chemotherapy

        Exclusion Criteria:

          -  Age ≥ 76

          -  Severe major organ dysfunction

          -  World Health Organization (WHO) performance status of &gt;1

          -  Prior cancer chemotherapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Da Fu, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>the Shanghai Tenth People's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Da Fu, Ph.D.</last_name>
    <phone>021-66301604</phone>
    <email>shsyiec@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ganzhou City People's Hospital</name>
      <address>
        <city>Ganzhou</city>
        <state>Jiangxi</state>
        <zip>341000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaoming Zhong, MD</last_name>
      <phone>00-86-797-8356156</phone>
      <email>15979192617@163.com</email>
    </contact>
    <investigator>
      <last_name>Xiaoming Zhong, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shanghai Tenth People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200072</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Da Fu, Ph.D.</last_name>
      <phone>00-86-21-66301604</phone>
      <email>fu800da900@126.com</email>
    </contact>
    <investigator>
      <last_name>Yushui Ma, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.</citation>
    <PMID>25651787</PMID>
  </results_reference>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2016</study_first_submitted>
  <study_first_submitted_qc>September 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 28, 2016</study_first_posted>
  <last_update_submitted>September 27, 2016</last_update_submitted>
  <last_update_submitted_qc>September 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai 10th People's Hospital</investigator_affiliation>
    <investigator_full_name>Da Fu</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>CRC</keyword>
  <keyword>liver metastasis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Neoplasms, Second Primary</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Extracts</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The investigators are willing to share data.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

